Role of C7 in Resistance to Neisseria Infections

C7 在抵抗奈瑟菌感染中的作用

基本信息

  • 批准号:
    8134950
  • 负责人:
  • 金额:
    $ 24.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The complement system plays a critical role in the innate immune response to bacterial infection. Regardless whether the classical, the alternative, or the lectin pathway initiates complement activation, the complement system ultimately generates the membrane attack complex (MAC). The MAC, composed of C5b, C6, C7, C8, and C9 (C5b-9), not only has direct bacteriolytic activity but also modulates cellular immune response via soluble C5b-9 and sub- lytic MAC deposition on host nucleated cells. Individuals with deficiencies of C6, C7, and C8, but not C9 are at a uniquely higher risk for infection with Neisseria gonorrhoeae and Neisseria meningitidis. While there is a much high risk of infection in these individuals, paradoxically the risk of mortality is much lower than the general population. While is has been speculated that this is due to a lack of MAC dependent release of bacterial cell wall components and attenuation of inflammatory responses, there is little direct evidence to support this. Furthermore our understanding of the complexities of the interactions of the C5b-9 complex with the host immune response has been limited by a lack of animal models deficient in terminal complement components. The current proposal seeks to define the mechanisms by which C5b-9 enhances the ability of the host to resist Neisseria infections in a newly generated mouse with a targeted deficiency in C7. Using an established model of disseminated Neisseria gonorrhoeae infection, mice deficient in C7, and thus unable to form the membrane attack complex, will be investigated at the cellular and molecular levels in order to identify C5b-9 dependent pathways critical to the clearance and killing of the bacteria. These pathways will then be validated in vivo. The use of this novel model system should enhance not only our understanding of the role of C5b-9 in host defense against Neisseria infection but also our understanding of the mechanisms by which C5b-9 modulates immunologic processes in general. PUBLIC HEALTH RELEVANCE: This proposal seeks to define the mechanisms by which the membrane attack complex (MAC) of complement enhances the ability of the host to resist Neisseria infections. Using a newly developed C7 deficient mouse, we will identify and characterize MAC dependent cellular and molecular pathways critical to protection from Neisseria gonorrhoeae, and validate these findings in a whole animal model of Neisseria infection.
描述(由申请人提供):补体系统在对细菌感染的先天免疫应答中起关键作用。无论是经典途径、旁路途径还是凝集素途径启动补体激活,补体系统最终都会产生膜攻击复合物(MAC)。由C5 b、C6、C7、C8和C9(C5 b-9)组成的MAC不仅具有直接的溶菌活性,而且通过可溶性C5 b-9和亚溶解MAC沉积在宿主有核细胞上来调节细胞免疫应答。C6、C7和C8缺乏而非C9缺乏的个体感染淋病奈瑟菌和脑膜炎奈瑟菌的风险更高。虽然这些人感染的风险很高,但矛盾的是,死亡风险远低于一般人群。虽然已经推测这是由于细菌细胞壁组分的MAC依赖性释放的缺乏和炎症反应的减弱,但几乎没有直接证据支持这一点。此外,我们的理解的C5 b-9复合物与宿主免疫应答的相互作用的复杂性已受到限制,缺乏动物模型缺乏终末补体成分。目前的建议旨在确定C5 b-9增强宿主抵抗C7靶向缺陷的新产生小鼠中奈瑟氏菌感染的能力的机制。使用已建立的播散性淋病奈瑟菌感染模型,将在细胞和分子水平研究C7缺陷小鼠,从而无法形成膜攻击复合物,以鉴定对细菌清除和杀灭至关重要的C5 b-9依赖性途径。然后将在体内验证这些途径。使用这种新的模型系统,不仅应该提高我们的理解C5 b-9在宿主防御奈瑟氏菌感染的作用,而且我们的理解的机制,C5 b-9调节免疫过程一般。 公共卫生相关性:该建议旨在确定补体的膜攻击复合物(MAC)增强宿主抵抗奈瑟菌感染的能力的机制。使用新开发的C7缺陷小鼠,我们将确定和表征MAC依赖的细胞和分子途径的关键保护淋病奈瑟菌,并验证这些发现在整个动物模型的奈瑟菌感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL C BRAUN其他文献

MICHAEL C BRAUN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL C BRAUN', 18)}}的其他基金

Role of C7 in Resistance to Neisseria Infections
C7 在抵抗奈瑟菌感染中的作用
  • 批准号:
    7962860
  • 财政年份:
    2010
  • 资助金额:
    $ 24.41万
  • 项目类别:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
C3aR 和 C5aR 调节 MRL 小鼠的 T 细胞反应
  • 批准号:
    7903765
  • 财政年份:
    2009
  • 资助金额:
    $ 24.41万
  • 项目类别:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
C3aR 和 C5aR 调节 MRL 小鼠的 T 细胞反应
  • 批准号:
    7031858
  • 财政年份:
    2006
  • 资助金额:
    $ 24.41万
  • 项目类别:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
C3aR 和 C5aR 调节 MRL 小鼠的 T 细胞反应
  • 批准号:
    8397223
  • 财政年份:
    2006
  • 资助金额:
    $ 24.41万
  • 项目类别:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
C3aR 和 C5aR 调节 MRL 小鼠的 T 细胞反应
  • 批准号:
    7368084
  • 财政年份:
    2006
  • 资助金额:
    $ 24.41万
  • 项目类别:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
C3aR 和 C5aR 调节 MRL 小鼠的 T 细胞反应
  • 批准号:
    7570091
  • 财政年份:
    2006
  • 资助金额:
    $ 24.41万
  • 项目类别:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
C3aR 和 C5aR 调节 MRL 小鼠的 T 细胞反应
  • 批准号:
    7212120
  • 财政年份:
    2006
  • 资助金额:
    $ 24.41万
  • 项目类别:
Urinary Biomarkers in Murine MPGN
小鼠 MPGN 中的尿液生物标志物
  • 批准号:
    7140339
  • 财政年份:
    2005
  • 资助金额:
    $ 24.41万
  • 项目类别:
Urinary Biomarkers in Murine MPGN
小鼠 MPGN 中的尿液生物标志物
  • 批准号:
    6962745
  • 财政年份:
    2005
  • 资助金额:
    $ 24.41万
  • 项目类别:
The Role of C3a and C5a in BEA Induced Nephritis
C3a 和 C5a 在 BEA 诱发肾炎中的作用
  • 批准号:
    6532064
  • 财政年份:
    2002
  • 资助金额:
    $ 24.41万
  • 项目类别:

相似海外基金

Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
  • 批准号:
    10607815
  • 财政年份:
    2023
  • 资助金额:
    $ 24.41万
  • 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
  • 批准号:
    10723868
  • 财政年份:
    2023
  • 资助金额:
    $ 24.41万
  • 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
  • 批准号:
    10862033
  • 财政年份:
    2023
  • 资助金额:
    $ 24.41万
  • 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
  • 批准号:
    10622209
  • 财政年份:
    2023
  • 资助金额:
    $ 24.41万
  • 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
  • 批准号:
    22H03963
  • 财政年份:
    2022
  • 资助金额:
    $ 24.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
  • 批准号:
    10537709
  • 财政年份:
    2022
  • 资助金额:
    $ 24.41万
  • 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
  • 批准号:
    10356565
  • 财政年份:
    2022
  • 资助金额:
    $ 24.41万
  • 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
  • 批准号:
    10708827
  • 财政年份:
    2022
  • 资助金额:
    $ 24.41万
  • 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
  • 批准号:
    10388929
  • 财政年份:
    2022
  • 资助金额:
    $ 24.41万
  • 项目类别:
Role of natural immunity to self apoptotic exosomes in maintaining immune homeostasis
对自凋亡外泌体的自然免疫在维持免疫稳态中的作用
  • 批准号:
    RGPIN-2021-03004
  • 财政年份:
    2022
  • 资助金额:
    $ 24.41万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了